@article{2227700518f24205826950b4a7b732f8,
title = "BAD on the Runs: Improved Diagnosis of Idiopathic Bile Acid Diarrhea",
author = "Michael Camilleri",
note = "Funding Information: Michael Camilleri{\textquoteright}s work on bile acids is supported by Grant R01-DK115950 from the National Institutes of Health. Funding Information: Michael Camilleri has received research grants from Novartis for study of tropifexor and from Allergan for study of eluxadoline in bile acid diarrhea. Though Dr. Camilleri is a full-time employee of Mayo Clinic which commercializes serum C4 and fecal bile acid measurements for bile acid diarrhea, Dr. Camilleri has no personal financial conflict of interest. ",
year = "2022",
month = mar,
doi = "10.1007/s10620-021-07044-9",
language = "English (US)",
volume = "67",
pages = "745--747",
journal = "Digestive diseases and sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "3",
}